Distribution and significance of interstitial fibrosis and stroma-infiltrating B cells in tongue squamous cell carcinoma

Oncology Letters

Volumn 11, Issue 3, 2016, Pages 2027-2034

  Lao, Xiao Mei ^a   Liang, Yu Jie ^a   Su, Yu Xiong ^b   Zhang, Si En ^a   Zhou, Xi ^a   Liao, Gui Qing ^a  

^a SUN YAT SEN UNIVERSITY   (China)

^b UNIVERSITY OF HONG KONG   (Hong Kong)

Author keywords

Cancer associated fibroblasts; Inflammatory microenvironment; Interstitial fibrosis; Stroma infiltrating B cells; Tongue squamous cell carcinoma

Indexed keywords

ALPHA SMOOTH MUSCLE ACTIN; CD19 ANTIBODY; DESMIN; VIMENTIN;

ADULT; AGED; ARTICLE; B LYMPHOCYTE; CANCER STAGING; CELL DIFFERENTIATION; CELL INFILTRATION; CELLULAR DISTRIBUTION; CONTROLLED STUDY; DISEASE ASSOCIATION; DYSPLASIA; FEMALE; FIBROSING ALVEOLITIS; HUMAN; HUMAN TISSUE; IMAGE ANALYSIS; IMMUNOHISTOCHEMISTRY; INFLAMMATION; MAJOR CLINICAL STUDY; MALE; MIDDLE AGED; OVERALL SURVIVAL; TONGUE CARCINOMA; TUMOR MICROENVIRONMENT;

EID: 84958035393     PISSN: 17921074     EISSN: 17921082     Source Type: Journal    
DOI: 10.3892/ol.2016.4184     Document Type: Article

References (29)

1. Albini A and Sporn MB: The tumour microenvironment as a target for chemoprevention. Nat Rev Cancer 7: 139–147, 2007.
2. Jemal A, Siegel R, Xu J and Ward E: Cancer statistics, 2010. CA Cancer J Clin 60: 277–300, 2010.
3. Aggarwal BB, Vijayalekshmi RV and Sung B: Targeting inflammatory pathways for prevention and therapy of cancer: Short–term friend, long–term foe. Clin Cancer Res 15: 425–430, 2009.
4. Erdag G, Schaefer JT, Smolkin ME, Deacon DH, Shea SM, Dengel LT, Patterson JW and Slingluff CL: Immunotype and immunohistologic characteristics of tumor–infiltrating immune cells are associated with clinical outcome in metastatic melanoma. Cancer Res 72: 1070–1080, 2012.
5. Nielsen JS, Sahota RA, Milne K, Kost SE, Nesslinger NJ, Watson PH and Nelson BH: CD20+ tumor–infiltrating lymphocytes have an atypical CD27– memory phenotype and together with CD8+ T cells promote favorable prognosis in ovarian cancer. Clin Cancer Res 18: 3281–3292, 2012.
6. Shi JY, Gao Q, Wang ZC, Zhou J, Wang XY, Min ZH, Shi YH, Shi GM, Ding ZB, Ke AW, et al: Margin–infiltrating CD20(+) B cells display an atypical memory phenotype and correlate with favorable prognosis in hepatocellular carcinoma. Clin Cancer Res 19: 5994–6005, 2013.
7. François A, Chatelus E, Wachsmann D, Sibilia J, Bahram S, Alsaleh G and Gottenberg JE: B lymphocytes and B–cell activating factor promote collagen and profibrotic markers expression by dermal fibroblasts in systemic sclerosis. Arthritis Res Ther 15: R168, 2013.
8. Shimoda M, Mellody KT and Orimo A: Carcinoma–associated fibroblasts are a rate–limiting determinant for tumour progression. Semin Cell Dev Biol 21: 19–25, 2010.
9. Räsänen K and Vaheri A: Activation of fibroblasts in cancer stroma. Exp Cell Res 316: 2713–2722, 2010.
10. Tripathi M, Billet S and Bhowmick NA: Understanding the role of stromal fibroblasts in cancer progression. Cell Adh Migr 6: 231–235, 2012.
11. DeFilippis RA, Chang H, Dumont N, Rabban JT, Chen YY, Fontenay GV, Berman HK, Gauthier ML, Zhao J, Hu D, et al: CD36 repression activates a multicellular stromal program shared by high mammographic density and tumor tissues. Cancer Discov 2: 826–839, 2012.
12. Wheeler SE, Shi H, Lin F, Dasari S, Bednash J, Thorne S, Watkins S, Joshi R and Thomas SM: Enhancement of head and neck squamous cell carcinoma proliferation, invasion, and metastasis by tumor–associated fibroblasts in preclinical models. Head Neck 36: 385–392, 2014.
13. Sobin LH and Wittekind C (eds): TNM Classification of Malignant Tumours. 6th edition. John Wiley & Sons, Hoboken, NJ, 2002.
14. Thompson L: World Health Organization classification of tumours: Pathology and genetics of head and neck tumours. Ear Nose Throat J 85: 74, 2006.
15. Etemad-Moghadam S, Khalili M, Tirgary F and Alaeddini M: Evaluation of myofibroblasts in oral epithelial dysplasia and squamous cell carcinoma. J Oral Pathol Med 38: 639–643, 2009.
16. Chaudhary M, Gadbail AR, Vidhale G, Mankar Gadbail MP, Gondivkar SM, Gawande M and Patil S: Comparison of myofibroblasts expression in oral squamous cell carcinoma, verrucous carcinoma, high risk epithelial dysplasia, low risk epithelial dysplasia and normal oral mucosa. Head Neck Pathol 6: 305–313, 2012.
17. Thode C, Jørgensen TG, Dabelsteen E, Mackenzie I and Dabelsteen S: Significance of myofibroblasts in oral squamous cell carcinoma. J Oral Pathol Med. 40: 201–207, 2011.
18. Maletzki C, Jahnke A, Ostwald C, Klar E, Prall F and Linnebacher M: Ex–vivo clonally expanded B lymphocytes infiltrating colorectal carcinoma are of mature immunophenotype and produce functional IgG. PLoS One. 7: e32639, 2012.
19. Dumont N, Liu B, Defilippis RA, Chang H, Rabban JT, Karnezis AN, Tjoe JA, Marx J, Parvin B and Tlsty TD: Breast fibroblasts modulate early dissemination, tumorigenesis and metastasis through alteration of extracellular matrix characteristics. Neoplasia 15: 249–262, 2013.
20. De Wever O, Van Bockstal M, Mareel M, Hendrix A and Bracke M: Carcinoma–associated fibroblasts provide operational flexibility in metastasis. Semin Cancer Biol 25: 33–46, 2014.
21. Tlsty TD and Coussens LM: Tumor stroma and regulation of cancer development. Annu Rev Pathol 1: 119–150, 2006.
22. Li T, Sun L, Miller N, Woo J, Hulse–Smith L, Tsao MS, Khokha R, Martin L and Boyd N: The association of measured breast tissue characteristics with mammographic density and other risk factors for breast cancer. Cancer Epidemiol Biomarkers Prev 14: 343–349, 2005.
23. Agarwal P and Ballabh R: Expression of type IV collagen in different histological grades of oral squamous cell carcinoma: An immunohistochemical study. J Cancer Res Ther 9: 272–275, 2013.
24. Olkhanud PB, Damdinsuren B, Bodogai M, Gress RE, Sen R, Wejksza K, Malchinkhuu E, Wersto RP and Biragyn A: Tumor–evoked regulatory B cells promote breast cancer metastasis by converting resting CD4+ T cells to T–regulatory cells. Cancer Res 71: 3505–3515, 2011.
25. Fremd C, Schuetz F, Sohn C, Beckhove P and Domschke C: B cell–regulated immune responses in tumor models and cancer patients. Oncoimmunology 2: e25443, 2013.
26. Nelson BH: CD20+ B cells: The other tumor–infiltrating lymphocytes. J Immunol 185: 4977–4982, 2010.
27. Mahmoud SM, Lee AH, Paish EC, Macmillan RD, Ellis IO and Green AR: The prognostic significance of B lymphocytes in invasive carcinoma of the breast. Breast Cancer Res Treat 132: 545–553, 2012.
28. Erez N, Truitt M, Olson P, Arron ST and Hanahan D: Cancer–associated fibroblasts are activated in incipient neoplasia to orchestrate tumor–promotinginflammation in an NF–kappaB–dependent manner. Cancer Cell 17: 135–147, 2010.
29. De Wever O, Demetter P, Mareel M and Bracke M: Stromal myofibroblasts are drivers of invasive cancer growth. Int J Cancer 123: 2229–2238, 2008.